Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT)

被引:2
作者
Miron-Rubio, Manuel [1 ,2 ]
Parra Jordan, Juan Jose [3 ]
Gonzalez Ramallo, Victor Jose [4 ]
Mujal Martinez, Abel [5 ]
Fernandez Muixi, Josefina [6 ]
Iglesias Gallego, Marina [7 ]
Lucas Nunez, Maria Cruz [8 ]
Rodado Alabau, Elisa [9 ]
Perez-Campoamor, Sandra Vidal [10 ]
Uria, Estefany [11 ]
机构
[1] Hosp Univ Torrejon, Unidad Hospitalizac, Torrejon De Ardoz, Madrid, Spain
[2] Univ Francisco Vitoria, Fac Med, Madrid, Spain
[3] Hosp Univ Marques Valdecilla, Unidad Hospitalizac & Domicilio, Santander, Santander, Spain
[4] Hosp Gen Univ Gregorio Maranon, Unidad Hospitalizac & Domicilio, Madrid, Madrid, Spain
[5] Hosp Univ Parc Tauli, Unidad Hospitalizac & Domicilio, Sabadell, Barcelona, Spain
[6] Pius Hosp Valls, Unidad Hospitalizac & Domicilio, Serv Med Interna, Valls, Tarragona, Spain
[7] Hosp Barbanza, Unidad Hospitalizac & Domicilio, Ribeira, A Coruna, Spain
[8] Hosp Univ Burgos, Unidad Hospitalizac & Domicilio, Burgos, Burgos, Spain
[9] Verge Cinta, Unidad Hospitalizac Domicilio, Tortosa, Tarragona, Spain
[10] Merck Sharp & Dohme Ltd, Madrid, Spain
[11] Pharmalex Spain, Market Access Area, Barcelona, Spain
关键词
Hospital at home; outpatient parenteral antimicrobial therapy (OPAT); cost analysis; skin and skin structure infections (SSSIs); SOFT-TISSUE INFECTIONS; RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL THERAPY; COMPLICATED SKIN; MANAGEMENT; EXPERIENCE; ADULTS; UK; EPIDEMIOLOGY; ORITAVANCIN;
D O I
10.37201/req/134.2022
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objective. To describe and quantify resource use and direct health costs associated with skin and skin structure infections (SSSIs) caused by Gram-positive bacteria in adults receiving outpatient parenteral antimicrobial therapy (OPAT), administered by Hospital at Home units (HaH) in Spain. Material and methods. Observational, multicenter, retrospective study. We included patients of both sexes included in the HaH-based OPAT Registry during 2011 to 2017 who were hospitalized due to SSSIs caused by Gram-positive bacteria. Resource use included home visits (nurses and physician), emergency room visits, conventional hospitalization stay, HaH stay and antibiotic treatment. Costs were quantified by multiplying the natural units of the resources by the corresponding unit cost. All costs were updated to 2019 euros. Results. We included 194 episodes in 189 patients from 24 Spanish hospitals. The most frequent main diagnoses were cellulitis (26.8%) and surgical wound infection (24.2%), and 94% of episodes resulted in clinical improvement or cure after treatment. The median HaH stay was 13 days (interquartile range [IR]:8-22.7), and the conventional hospitalization stay was 5 days (IR: 1-10.7). The mean total cost attributable to the complete infectious process was _7,326 (95% confidence interval: _6,316-_8,416). Conclusions. Our results suggest that OPAT administered by HaH is a safe and efficient alternative for the management of these infections and could lead to lower costs compared with hospital admission.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 16 条
  • [11] Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019)
    Carvalhaes, Cecilia Godoy
    Sader, Helio Silva
    Rhomberg, Paul Richard
    Castanheira, Mariana
    DeVries, Sean
    Mendes, Rodrigo Elisandro
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (09) : 731 - 735
  • [12] Assessing the economic value of avoiding hospital admissions by shifting the management of gram plus acute bacterial skin and skin-structure infections to an outpatient care setting
    Ektare, V.
    Khachatryan, A.
    Xue, M.
    Dunne, M.
    Johnson, K.
    Stephens, J.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (12) : 1092 - 1101
  • [13] Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
    O'Riordan, William
    Tiffany, Courtney
    Scangarella-Oman, Nicole
    Perry, Caroline
    Hossain, Mohammad
    Ashton, Teri
    Dumont, Etienne
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [14] Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015)
    Pfaller, Michael A.
    Mendes, Rodrigo E.
    Sader, Helio S.
    Castanheira, Mariana
    Flamm, Robert K.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 11 : 4 - 7
  • [15] In Vitro Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections
    Prokocimer, Philippe
    Bien, Paul
    DeAnda, Carisa
    Pillar, Chris M.
    Bartizal, Ken
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4608 - 4613
  • [16] A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1
    Huang, David B.
    O'Riordan, William
    Overcash, J. Scott
    Heller, Barry
    Amin, Faisal
    File, Thomas M.
    Wilcox, Mark H.
    Torres, Antoni
    Dryden, Matthew
    Holland, Thomas L.
    McLeroth, Patrick
    Shukla, Rajesh
    Corey, G. Ralph
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (08) : 1222 - 1229